NEW YORK (GenomeWeb) – Cancer Genetics reported today that total first quarter 2015 revenues more than tripled year over year.

The Rutherford, New Jersey-based firm said that for the first three months of 2015 it took in $4.4 million in total revenues, up from $1.4 million in the year ago quarter, due to a revenue contribution from acquisitions and an increase in volume of the firm's SelectOne clinical trials services. Revenues were in line with the consensus Wall Street estimate of $4.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.